China Money Network
Login
Join

Sequoia Joins $32M Round In China’s Oncology-Focused EOC Pharma

  • November 8, 2017 — 10:16 CST

This Data Is Locked!

This area is available only to Subscribers.

China’s Taikang Investment has led a US$32 million series B round in EOC Pharma Group, an oncology-focused development company, through its healthcare and consumer industry-focused... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Join

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?

Login
Related Topics:

Related Data: